Over 200 million major medical procedures are performed globally each year
Last year, doctors spent $100 million on fluorescence injections and sound probes to assess quality of blood flow in heart bypass, vascular, transplants, plastics, & general surgeries
Scinovia created a state-of-the-art laser biophotonics device to enable doctors to remotely visualize actual blood flow speeds across vessels & tissue–no injections, no probes, no additional instruments
10 renowned surgeons comprise Scinovia Medical Advisory Board
PLATFORM TECHNOLOGY
Various form factors from NOVIA platform technology
PRODUCT MILESTONES
2015
- Developed breakthrough capability for non-contact measurement of fast to slow blood flow speeds in vessels at or near the surface
2016
- Testing in various vet surgeries
- Preparing for regulatory submission – CE Mark & US FDA Class II, 510(k) strategy & draft application (by former FDA Branch Chief)
2017
- Finished product
- External testing
- Gen-1 Regulatory clearance in EU
- Commercialization
2018
- Gen-2 Regulatory clearance EU, US, CA
- Commercialization
.
Scinovia Corp
Europe, US, Singapore
info @ Scinovia com
